Myotonia

Mexiletine Associated With Better Reduction in Muscle Stiffness Than Placebo in Nondystrophic Myotonia

Brandon May

January 29, 2019

Findings support the efficacy of mexiletine and the potential value of N-of-1 trials for assessing interventions in some chronic rare diseases.

Neuromuscular Disorders

New Scoring System for Predicting Survival in Myotonic Dystrophy Type 1

Sheila Jacobs

March 1, 2018

Age, diabetes, need for support when walking, heart rate, systolic blood pressure, first-degree atrioventricular block, bundle-branch block, and vital lung capacity were all linked to death.

Next post in Neuromuscular Disorders

Myotonia

Mexiletine Associated With Better Reduction in Muscle Stiffness Than Placebo in Nondystrophic Myotonia

New Scoring System for Predicting Survival in Myotonic Dystrophy Type 1

Arimoclomol Shows Promise for Treating Rapidly Progressive SOD1 ALS